Concepedia
Statistics
Publications
14
Citations
2.3K
H-Index
12
Active since
1989
Affiliations
University of Alberta(Current)
University of British Columbia
Inserm
Gilead Sciences (United States)
William Osler Health System
Stephen D. Shafran is an author at University of Alberta specializing in infectious diseases, antiviral therapy, and pharmacy.
Publications per year
1989–2020
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
Jordan J. Feld, Ira M. Jacobson, Christophe Hézode et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +17
Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV Genotype 2 or 3
Mitchell L. Shiffman, Fredy Suter, Bruce R. Bacon et al. · New England Journal of Medicine · 2007 · 490 citations · Full text
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
Ira M. Jacobson, Eric Lawitz, Edward Gane et al. · Gastroenterology · 2017 · 239 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +12
Sofosbuvir/velpatasvir for 12 weeks in hepatitis C virus-infected patients with end-stage renal disease undergoing dialysis
Sergio Borgia, Janet Dearden, Eric M. Yoshida et al. · Journal of Hepatology · 2019 · 123 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +15
Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts
Alessandra Mangia, Scott Milligan, Mandana Khalili et al. · Liver International · 2020 · 105 citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +16
1–5 of 14